Inhibition of Src with AZD0530 Reveals the Src-Focal Adhesion Kinase Complex as a Novel Therapeutic Target in Papillary and Anaplastic Thyroid Cancers

פריטים דומים

• Inhibition of Src with AZD0530 Reveals the Src-Focal Adhesion Kinase Complex as a Novel Therapeutic Target in Papillary and Anaplastic Thyroid Cancer
  מאת: Schweppe, Rebecca E., et al.
  יצא לאור: (2009)
• Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
  מאת: Green, Tim P., et al.
  יצא לאור: (2009)
• Phase II Study of the Src Kinase Inhibitor Saracatinib (AZD0530) in Metastatic Melanoma
  מאת: Gangadhar, Tara C., et al.
  יצא לאור: (2012)
• Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530
  מאת: Chang, Y-M, et al.
  יצא לאור: (2008)
• The effect of the dual Src/Abl kinase inhibitor AZD0530 on Philadelphia positive leukaemia cell lines
  מאת: Gwanmesia, Patricia Mambou, et al.
  יצא לאור: (2009)